References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: Cancer J Clinicians. 2016;66(1):7–30.
- Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nature Med 2011;17(11):1498–1503.
- Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nature Rev Mol Cell Biol 2007;8(10):774–785.
- Celenza JL, Carlson M. A yeast gene that is essential for release from glucose repression encodes a protein kinase. Science. 1986;233(4769):1175–1180.
- Ghillebert R, Swinnen E, Wen J, Vandesteene L, Ramon M, Norga K, et al. The AMPK/SNF1/SnRK1 fuel gauge and energy regulator: structure, function and regulation. FEBS J 2011;278(21):3978–3990.
- Yoshida K, Yamada M, Nishio C, Konishi A, Hatanaka H. SNRK, a member of the SNF1 family, is related to low K(+)-induced apoptosis of cultured rat cerebellar granule neurons. Brain Res 2000;873(2):274–282.
- Chun CZ, Kaur S, Samant GV, Wang L, Pramanik K, Garnaas MK, et al. Snrk-1 is involved in multiple steps of angioblast development and acts via notch signaling pathway in artery-vein specification in vertebrates. Blood 2009;113(5):1192–1199.
- Cossette SM, Gastonguay AJ, Bao X, Lerch-Gaggl A, Zhong L, Harmann LM, et al. Sucrose non-fermenting related kinase enzyme is essential for cardiac metabolism. Biol Open 2014;4(1):48–61.
- Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008;30(2):214–226.
- Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, et al. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 2004;23(34):5853–5857.
- Behbakht K, Sill MW, Darcy KM, Rubin SC, Mannel RS, Waggoner S, et al. Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 2011;123(1):19–26.
- Jaleel M, McBride A, Lizcano JM, Deak M, Toth R, Morrice NA, et al. Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate. FEBS Lett 2005;579(6):1417–1423.
- Rines AK, Burke MA, Fernandez RP, Volpert OV, Ardehali H. Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of beta-catenin. FASEB J 2012;26(11):4685–4695.
- Bishop EC, Padmanabhan S, Ramchandran VR., editors. Sucrose nonfermenting 1-related kinase (SNRK) expression and function in vitro in ovarian cancer cells [abstract]. Proceedings of the 10th Biennial Ovarian Cancer Research Symposium, Seattle, WA; 2014.
- Li Y, Nie Y, Helou Y, Ding G, Feng B, Xu G, et al. Identification of sucrose non-fermenting-related kinase (SNRK) as a suppressor of adipocyte inflammation. Diabetes 2013;62(7):2396–2409.
- Fogarty S, Hardie DG. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochimica et Biophysica Acta. 2010;1804(3):581–591.